General Information of Drug (ID: DMWX683)

Drug Name
Mupirocin Drug Info
Synonyms
Bactoderm; Bactroban; Centany; MRC; Mupirocina; Mupirocine; Mupirocinum; Plasimine; Bactroban Nasal; Mupirocina [Spanish]; Mupirocine [French]; Mupirocinum [Latin]; Pseudomonic acid; Pseudomonic acid A; BRL 4910A; BRL-4910A; Bactroban (TN); Centany (TN); Mupirocin (USP/INN); Mupirocin, 14C-Labeled; 5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-[2E,8[2S,3S(1S,2S); 8-Carboxyoctyl (E)-4-(2S,3R,4R,5S)-5-((2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl)-3,4-dihydroxytetrahydro-2H-pyran-2-yl)-3-methylcrotonat; 9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid
Therapeutic ClassAntibiotics
Cross-matching ID
PubChem CID
446596
ChEBI ID
CHEMBL719
CAS Number
CAS 12650-69-0
TTD Drug ID
D03JSJ
ACDINA Drug ID
D01263

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Retinol metabolism 2.08 1.09e-2 41/68 (60.29%) DHRS3;CYP2C8;ADH1C;...
Spliceosome 2.03 5.44e-3 101/150 (67.33%) SRSF1;PUF60;SF3B2;...
Bile secretion 1.96 3.62e-3 68/90 (75.56%) AQP1;SLC4A4;FXYD2;...
Metabolism of xenobiotics by cytochrome P450 1.92 5.44e-3 49/77 (63.64%) CYP1B1;GSTT1;ADH1C;...
Vibrio cholerae infection 1.90 6.52e-3 44/50 (88%) PRKCA;ATP6V0E2;ACTB;...
Histidine metabolism 1.85 1.45e-2 16/22 (72.73%) MAOB;HNMT;AOC1;...
DNA replication 1.84 2.02e-2 34/36 (94.44%) MCM5;PRIM2;POLD4;...
Primary bile acid biosynthesis 1.75 3.67e-2 15/17 (88.24%) AKR1C4;AMACR;BAAT;...
Pentose phosphate pathway 1.72 4.95e-2 25/30 (83.33%) ALDOB;PFKP;PFKL;...
Proximal tubule bicarbonate reclamation 1.71 4.68e-2 21/23 (91.3%) AQP1;SLC4A4;GLUD2;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 10uM 6H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 10uM 6H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 10uM 6H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 10uM 6H